Table 1. Patient and treatment characteristics.
| All (n = 12) | Diabetics (n = 5) | Non-Diabetics (n = 7) | p | |
|---|---|---|---|---|
| Female (n) | 6 | 4 | 2 | |
| Age (y) | 53 (32–80) | 54 (47–80) | 53 (32–71) | 0.19 |
| M (kg) | 71.9 ± 14.5 | 63.4 ± 10.3 | 78.0 ± 14.5 | 0.08 |
| Height (cm) | 170.3 ± 8.9 | 165.2 ± 10.0 | 174.0 ± 6.6 | 0.09 |
| BMI (kg/m2) | 24.7 ± 3.9 | 23.1 ± 2.4 | 25.7 ± 4.6 | 0.27 |
| A (m2) | 1.8 ± 0.2 | 1.7 ± 0.2 | 1.9 ± 0.2 | 0.06 |
| Dialysis vintage (mo) | 82.0 ± 60.5 | 77.8 ± 65.8 | 85.0± 61.5 | 0.85 |
| Vuf (L) | 1.86 ± 0.46 | 1.85 ± 0.53 | 1.87 ± 0.44 | 0.95 |
| Na+d (mmol/L) | 137.9 ± 2.6 | 138.3 ± 1.6 | 137.6 ± 3.3 | 0.66 |
| Qb (mL/min) | 288 ± 20 | 278 ± 18 | 294 ± 19 | 0.17 |
| HDF (n) | 10 | 3 | 7 | |
| HD (n) | 2 | 2 | 0 | |
| ACE-Inhibitor | 1 | 1 | 0 | |
| ß-blocker | 5 | 2 | 3 |
n: number of subjects; p: probability; M: body mass at dry weight; BMI: body mass index; A: body surface area; V uf: ultrafiltration volume; Na+ d dialysate sodium concentration; Q b: extracorporeal blood flow; HDF: hemodiafiltration: HD: hemodialysis; ACE: angiotensin-converting-enzyme